王鑑忠

1. Lee WL, Kong CW, Wang JJ, Chan WL, Wang SP, Chang MS. Atrial demand pacing in patients with symptomatic sick sinus syndrome. JPN Heart J 1994;35:625-633.（SCI）
2. Wang JJ, Chan WL, Kong CW, Lee WL, Wang SP, Chang MS. Hemodynamic mechanism of vasovagal syncope. JPN Heart J 1996;37:361-371.（SCI）
3. Lee WL, Chen JW, Kong CW, Wang JJ, Ting CT, Chan WL, Wang SP, Chang MS. Changes in cardiac autonomic activities in patients with syndrome X. A study of spectral analysis of heart rate variability. Angiology 1996;47:929-39.
4. Kong CW, Lee WL, Hsu TL, Chan WL, Wang JJ, Liou JY, Wang SP, Chang MS. Effects of right ventricular pacing on ventriculoatrial conduction and systemic responses in sick sinus patients. Angiology 1996;47:973-80.
5. Chung N, Cho SY, Choi DH, Zhu JR, Lee K, Lee PY, Lee SH, Lee S, Wang JJ, Yin WH, et al. STATT: a titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target. Clin Ther 2001 Jun;23(6):858-70. (SCI)
6. Wang JJ, Yin WH, Huang CM, Jen HL, Young MS, Wei J. Predictors of cardiogenic shock complicating acute myocardial infarction and effects of early revascularization on mortality. Acta Cardiol Sin 2003;19:71-80.
7. Chiang MC, Yin WH, Jen HL, Wang JJ, Huang WP, Feng AN, Young MS. Vascular cell adhesion molecule-1 as a prognostic marker in patients with end-stage heart failure. Acta Cardiol Sin 2004;20:94-104.
8. Yin WH, Chen JW, Jen HL, Wang JJ, Huang WP, Feng AN, Chiang MC, Yang YN, Young MS, Lin SJ. Inhibitory effect of simvastatin, an HMG-COA reductase inhibitor, on endothelial monocyte adhesion in patients with severe congestive heart failure. Int J Cardiol 2004;97(Suppl 2):S59.
9. Chiang MC, Yin WH, Lin YT, Jen HL, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Brachial artery distensibility as a cardiovascular risk marker in asymptomatic individuals. J Intern Med Taiwan 2005;16:1-10.
10. Wang JJ, Huang WP, Yin WH, Young MS, Wei J. Application of cutting balloon angioplasty for undilatable venous stenoses causing dialysis access dysfunction. Acta Cardiologica Sinica 2006;22:91-95.
11. Wang JJ, Tung TH, Yin WH, Huang CM, Jen HL, Wei J, Young MS. Effects of Moderate Alcohol Consumption on Inflammatory Biomarkers. Acta Cardiol 2008; 63: 65-72.

CASE REPORT:

1. Wu JJ, Yu TJ, Wang JJ, Wen YS, Liu M, Lee CH. Early repair of traumatic ventricular septal defect and mitral valve regurgitation. J Trauma 1995;39:1191-3.
   CONFERENCE PAPER:
2. Huang CM, Young MS, Liu BY, Jen HL, Wang JJ, Yang YN, Wei JH, Chiang MC, Yin WH, et al. Natural history and predictors of 1-year outcome in Chinese patients with severe heart failure for heart transplantation. (Abstract) Acta Cardiol Sin 2000;16(Suppl):4.
3. Huang CM, Yang YN, Wei JH, Huang HS, Jen HL, Wang JJ, Chiang MC, Huang WB, Yin WH, et al. Transradial coronary intervention in Chinese patients: a single-center experience. (Abstract) Acta Cardiol Sin 2001;17(Suppl):115.
4. Wang JJ, Yin WH, Huang CM, Jen HL, Chiang MC, Huang WP, congenital anomalies of the coronary arteries: a coronary arteriographic study. (Abstract) Acta Cardiol Sin 2003;19(Suppl):P39.
5. Huang CM, Yang YN, Wang JJ, Chiang MC, Young MS. Coronary stenting in patient>65 years of age: transradial approach is a safe and effective alternative to femoral route but old age is associated with higher vascular complications and worse long-term outcome. (Abstract) Acta Cardiol Sin 2004;20(SuppII):210.
6. Chiang MC, Yin WH, Lin YT, Jen HL, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Usefulness of brachial artery distensibility in the prediction of coronary risk among asymptomatic individuals with and without metabolic syndrome. 2005; 1st International Congress on “Prediabetes” and the metabolic syndrome. (Abstract)
7. Wang JJ, Tung TH, Yin WH, Huang CM, Jen HL, Chiang MC, Huang WP, Feng AN, Yang YN, Young MS, Wei J. Influence of habitual alcohol consumption and lifestyle on high sensitivity c-reactive protein levels. (Abstract) Acta Cardiol Sin 2005;21(Suppl III):200.
8. Jen HL, Yin WH, Chiang MC, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Use of statins prior to PCI with drug-eluting stenting reduces myonecrosis and improves clinical outcomes. (Abstract) 2005; Complex Catheter Therapeutics 2005.
9. Jen HL, Yin WH, Chiang MC, Wang JJ, Huang WP, Feng AN, Yang YN, Young MS. Use of statins prior to percutaneous coronary intervention with drug-eluting stent reduces myonecrosis and improves clinical outcome. (Abstract) Acta Cardiol Sin 2005;21(Suppl III):179.
10. Wei-Hsian Yin,Chin-Kun Tseng,Tien-Ping Tsao,Hsu-Lung Jen1,Wen-Pin Huang1,Chien-Lung Huang,Jiann-Jong Wang,Mason Shing Young:Transradial versus transfemoral rotablation for heavily calcified coronary lesions in contemporary drug-eluting stent era.Journal of Geriatric Cardiology (2015) 12: 489−496.